SREBF1 and metabolic dysfunction-associated steatotic liver disease: SREBP-1 is a transcription factor that plays a critical role in de novo lipogenesis (DNL), which is often induced in cases of NAFLD and in response to conditions such as endoplasmic reticulum (ER) stress, hyperglycemia, and oxidative stress [63–65].